The FDA Modernization of Cosmetic Regulations Act Update

 

MOCRA is an important step towards ensuring the safety and transparency of cosmetic products in the United States. The act aims to modernize the regulatory framework governing cosmetics and enhance the authority of the U.S. Food and Drug Administration (FDA) in overseeing the industry. One significant aspect of this act is the requirement for companies with over $1 million in annual sales to register their products with the FDA.

 

The recent deadline of July 1st marked an important milestone for companies falling under this registration requirement. It mandated that companies with annual sales exceeding $1 million, including those importing cosmetic products into the United States, register their products with the FDA. This registration process serves to provide the FDA with crucial information about the products being sold, allowing them to better monitor and regulate the cosmetic industry.

 

However, it is worth noting that the registration requirement does not apply to all cosmetic companies. Many small-scale businesses, such as mom-and-pop nail brands, are exempt from this requirement. This exemption is primarily due to the fact that these businesses typically have annual sales below the $1 million threshold. As a result, there are numerous cosmetic companies in the United States that do not have to register with the FDA.

 

While the registration requirement is a significant step in ensuring the safety and transparency of cosmetic products, it is important to recognize that there are still many companies operating within the industry that are not subject to this regulation. This highlights the diverse landscape of the cosmetic industry, with a mix of large corporations and small businesses catering to the market.

 

​